The new testing process is combined with HSL's Liquid Base Cytology service (for cervical screening) and enables the clinician to request HPV typing as well from the same specimen, promoting easier diagnosis.
Dr. Samar Hourieh, MD, director of Histopathology and Specialty Laboratory said:
"The new HPV test is an important step for identifying and treating cervical cancer, as well as raising awareness and improving women's health across the MENA region."
Established in 2000, HSL offers comprehensive and high quality Histopathology and Cytology services in the private sector.
Browse
related articles
Posted by Nadeen El Ajou
